Biomarkers

The Molecular EQA program ensures that biomarker testing meets the highest standards of accuracy and reliability, supporting proficiency testing as an important part of medical laboratory practice

Minimally invasive testing options can be less risky and less expensive compared to traditional, invasive biopsies

In a proof-of-concept study, the test detected five key biomarkers of Alzheimer’s disease—more than current commercially available blood tests can measure

First multicenter study of cell-free RNA and DNA methylation biomarkers in seminal fluid shows promise for accurate, noninvasive detection of clinically significant prostate cancer

Results from the first cohort of the AURORAX 087A study show the new biomarker-based test provides a more robust basis for making decisions on treatment than scans alone

The test could enable at-home testing and increased access to testing for patients undergoing telehealth care or living in remote areas

Nanopore-based sensors could transform diagnostics

New study offers hope that a simple test can be developed to identify preeclampsia earlier in pregnancy

Recent findings from scientists at St. Jude Children’s Research Hospital are showing promise for assessing cardiomyopathy risk in childhood cancer survivors

Better diagnostics for neurodegenerative diseases can improve clinical trials to help move groundbreaking therapies to approval